Drug Profile
Research programme: immunological disorder therapeutics - Kyowa Kirin/La Jolla Institute
Latest Information Update: 16 Jul 2019
Price :
$50
*
At a glance
- Originator La Jolla Institute for Allergy & Immunology
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for research development in Immunological-disorders in USA
- 31 Jul 2013 Early research in Immunological disorders in USA (unspecified route)